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ABSTRACT: Aldose reductase is the ﬁrst enzyme of the
polyol pathway in which glucose is converted to fructose via
sorbitol. The understanding of this key enzyme is important as
it has been linked to some diabetes mellitus complications.
The mechanism of the enzyme was investigated using a hybrid
quantum mechanics/molecular mechanics (QM/MM) meth-
od. It was found that depending on the protonation state of
His110 the mechanism can be concerted or stepwise and the
proton donor can be either Tyr48 or His110. These ﬁndings
are diﬀerent from the previous theoretical studies based on
QM/MM calculations using either AM1 or HF/4-31G, in
which the reduction is, respectively, a stepwise or one-step process. The QM/MM energy barriers for the reduction of D-
glyceraldehyde were evaluated at a B3LYP/6-31G* level for both HIP and HIE protonation states of His110. These were,
respectively, 6.5 ± 2.2 and 16.7 ± 1.0 kcal/mol, which makes only the HIE protonation state consistent with the experimental
value of 14.8 kcal/mol derived from kinetics experiments and makes Tyr48 the most probable proton donor.
1. INTRODUCTION
Aldose reductase (AR) (EC 1.1.1.21) is a cytosolic reduced
nicotinamide adenine dinucleotide phosphate (NADPH)-
dependent oxidoreductase enzyme that belongs to the
superfamily of aldo-keto reductases.1,2 Aldose reductase has
been identiﬁed as the ﬁrst enzyme involved in the polyol
pathway of glucose metabolism that converts glucose to
fructose via sorbitol.3 This is of particular interest for the
pharmaceutical industry as glucose overutilization through the
polyol pathway has been linked to tissue-based pathologies
associated with diabetes mellitus complications.3,4 AR has thus
been widely studied to develop potent AR inhibitors to prevent
or delay the onset and progression of these complications.5 As a
result, the protein data bank (PDB) accounts to date (February,
2017) for an impressive number of X-ray crystallographic
structures (136) of human aldose reductase.6
The human AR enzyme comprises 315 amino acid residues
and has a β/α barrel structure (Figure 1a,b).7 The barrel is
composed of eight parallel β-strands and eight adjacent
peripheral α-helical segments that are running antiparallel to
the β-sheet. The catalytic active site is located in the barrel core.
The nicotinamide adenine dinucleotide phosphate (NADP)
cofactor is situated at the top of the COOH-terminal end of the
β/α barrel, with the nicotinamide ring projecting into the
center of the barrel and the pyrophosphate part on the border
of the barrel.
The reaction mechanism of aldose reductase in the direction
of aldehyde reduction comprises two steps.8 The ﬁrst step is the
transfer of the pro-R hydride of NADPH to the re face of the
substrate’s carbonyl carbon. The second step is the donation of
a proton to reduce the carbonyl to an alcohol (Scheme 1).
Despite the acceptance of this general mechanism, several
key features remain unclear. On the one hand, it is not known
whether the reaction occurs in a concerted or stepwise manner.
On the other hand, it is not clear which of the proximal
residues, Tyr48 or His110, acts as the proton donor. Indeed,
both of these residues could potentially occupy this function, as
crystal structures indicate that they are well positioned to be
potential proton donors during catalysis; in crystal structure
1ADS, a water molecule in close proximity to the nicotinamide
is hydrogen bonded to both Tyr48 and His110 and thus
indicates a possible position for the substrate (Figure 1c). A
comparison of the relative pKas of the residues suggests that the
lower value of histidine (pKa = 6−7) relative to tyrosine (pKa =
10) would make it a more likely candidate to donate a
proton.9,10 However, the proximity of the Lys77−Asp43 pair in
the binding site has been proposed to lower the pKa of Tyr48−
8.25 through hydrogen bonding.10
In the literature, there are several computational studies that
investigate which of the two potential residues is the proton
donor.11−13 These include two quantum mechanics/molecular
mechanics (QM/MM) studies, one by Lee and co-workers13
and the other by Vaŕnai and co-workers,11 and one empirical
valence bond (EVB) study by Vaŕnai and Warshel.12 From the
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results of the two QM/MM studies, which are summarized in
Table 1, it is evident that they diﬀer in both their proposed
mechanisms and calculated energetics. The results of Lee and
co-workers13 show a concerted mechanism, whereas Vaŕnai and
co-workers reported a stepwise mechanism.11 The diﬀerence in
the calculated energetics of the reactions is also signiﬁcant, with
a diﬀerence for the calculated relative energies of around 10
kcal/mol. The experimental activation free energy, determined
from reaction rate studies, is 14.8 kcal/mol.14 Thus, both
computational studies overestimate the activation energy with a
relative energy of 21.3 kcal/mol for Lee and co-workers13 and
31.8 kcal for Vaŕnai and co-workers.11 Nevertheless, both
studies agree that the reaction mechanism is more favorable
with the His110 model than with the Tyr48 model, as the
relative activation energies in both studies are smaller when
employing His110 as the proton donor.
In the EVB study from Vaŕnai and Warshel,12 the energy
proﬁle was only evaluated for the tyrosine proton donor
hypothesis as their detailed pKa studies on both Tyr48 and
His110 suggested that the Tyr48 proton donor hypothesis
would be the most probable mechanism. The activation free
energy was calculated to be 17 kcal/mol and thus in good
agreement with experimental results. The better agreement of
the EVB results is not a surprise as the method comprises
signiﬁcant sampling and is thus able to evaluate free energies
that can be directly compared to experiment results. On the
Figure 1. (a, b) View of the α-carbon backbone trace (schematic diagram) of the aldose reductase structure with bound NADPH. (a) View
perpendicular to the β/α barrel with NADPH shown in green space-ﬁlling model. (b) The structure viewed down the COOH-terminal end of the β/
α barrel. (c) Aldose reductase active site (PDB ID: 1ADS) with crystallographic waters shown.
Scheme 1. Schematic Representation of Aldehyde Reduction
by Aldose Reductase
Table 1. Summary of Previous QM/MM Results for the
Reduction of D-Glyceraldehyde (GLD) by Aldose
Reductasea
study TS1 I TS2 P
Proton Donor His110
Lee et al.b 21.2 −12.4
Vaŕnai et al.c 31.8 25.4 35.4 −5.9
Proton Donor Tyr48
Lee et al.b 24.3 −3.7
Vaŕnai et al.c 41.2 33.6 34.7 10.3
aElectronic energies (ΔE) in kcal/mol are given relative to the
reactant state for each system studied. bRef 13. cRef 11.
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contrary, in the two QM/MM methods described above, no
sampling is included and thus only potential energies are
calculated. Entropic contributions are thus not included in
these original calculations. Although entropic and thermal
contributions can play a signiﬁcant role in determining
transition-state energies, previous work has shown that the
entropic contributions to the activation energies for some
enzyme reactions can be minimal,15 and as such the underlying
diﬀerence in the quality of the results between the EVB and
QM/MM calculations is not necessarily due entirely to the
exclusion of entropic eﬀects.
Overall, the opposing nature of the conclusions from these
two QM/MM studies, combined with the low chemical
accuracy of the calculated activation energies, indicates that a
more detailed study into this important mechanism is
warranted. In the present work, we have examined the catalytic
mechanism of aldose reductase with a QM/MM approach
employing this time density functional theory (DFT) as the
QM methodology. The structures of transition states (TSs) and
intermediates involved in the reaction, the energy proﬁles, and
the roles of key residues are presented herein. The detailed
interpretation of the catalytic mechanism that results from this
work is helpful for the design of mechanism-based inhibitors
like transition-state analogue or covalent inhibitors.16 Finally,
one of the main objectives of this work is to determine how the
methodological choices in a QM/MM calculation can have
signiﬁcant eﬀects on both the calculated energetics and the
resulting interpretation of the preferred mechanism. Therefore,
the extent to which using a modern density functional and a
larger QM region can aﬀect previous results, both quantitatively
and qualitatively, is also discussed.
2. RESULTS AND DISCUSSION
The proposed mechanism for the diﬀerent protonation states is
represented in Scheme 2, and the associated relative energies
are shown in Figure 2. To clearly diﬀerentiate the intermediates
from the diﬀerent models, a labeling scheme is introduced,
where the abbreviated name of the model (P for HIP, E for
HIE, and D for HID) precedes the abbreviated name of the
intermediate (R for reactant, TS for transition state, I for
intermediate, and P for product). Thus, we have for example
P−R that stands for reactant of the HIP model. In the following
sections, a detailed description of the three diﬀerent reaction
mechanisms is given.
2.1. Mechanism with HIP110. The results for the
mechanism of GLD reduction by AR in the case of a
protonated histidine show a single-step mechanism with
associated activation energy of 8.1 kcal/mol (Scheme 2a and
Figure 2). A schematic representation of the starting enzyme−
substrate (ES) complex (P−R), the transition state (P−TS1),
and the ﬁnal enzyme−product (EP) complex (P−P), including
only the closest atoms around substrate, is given in Figure 3a−
c, respectively.
Scheme 2. Proposed Mechanisms for the Diﬀerent Protonated States of His110: (a) HIP, (b) HIE, and (c) HID
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Signiﬁcant interactions help to maintain atoms in the ES
complex, P−R, in a suitable position for reactions, namely, H-
bonds between both His110 and Tyr48 hydroxyl group and the
carbonyl group of GLD (H5(His110)···O4(GLD) = 1.83 Å and
H6(Tyr48)···O4(GLD) = 2.02 Å), the H-bond between the
NADPH amide group and the 2-hydroxy of GLD (O8-
(NADPH)···H9(GLD) = 1.80 Å), and ﬁnally the H-bond
between the 3-hydroxy of GLD with a water molecule
(H(H2O)···O13(GLD) = 2.15 Å). In the transition state
(characterized by an imaginary frequency of −667 cm−1), the
NADPH hydride is approximately halfway between C1 and C3,
the C1···H2 and C3···H2 distances being 1.45 and 1.26 Å,
respectively (Figure 3b). In addition, the comparison of the
enzyme−substrate complex (Figure 3a) and TS (Figure 3b)
geometries shows the beginning of transition from a planar sp2
to a tetrahedral sp3 for the GLD carboxyl. In the same way, the
donation of the hydride by NADPH makes the nicotinamide
ring become more planar. The TS structure, P−TS1, does not
clearly show whether His110 or Tyr48 is the proton donor:
both H5 from His110 and H6 from Tyr48 are now closer to O4
(GLD) (H5(His110)···O4(GLD) distance is 1.61 Å and
H6(Tyr48)···O4(GLD) distance is 1.83 Å), and these may
contribute to the stabilization of the TS. However, from the
product complex (Figure 3c), it is clear that the proton donor is
Figure 2. Comparison of relative energies for the three protonation
models: HIP, HIE, and HID. Electronic energies (ΔE) in kcal/mol,
calculated at the B3LYP/6-31G* level, are given relative to the
reactant state for each system studied.
Figure 3. (a−c) Reaction intermediates of the GLD reduction by AR with HIP110 as studied by the QM/MM model. (a) Enzyme−substrate
complex, (b) transition state, (c) enzyme−product complex (distances shown in green, atom numbers in brown, and residue names in red), and (d)
superposition of the three intermediates of the reaction (P−R in pink, P−TS1 in green, P−P in cyan, and hydride in yellow).
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His110; thus, the role of Tyr48 is stabilizing the incipient
negative charge on the aldehyde group of GLD. From these
results, it can be concluded that the mechanism for the
protonated histidine system is concerted and asynchronous,
where the approach of the NADPH hydride to the carbonyl
carbon of GLD triggers the proton transfer. In the ﬁnal product
complex (EP), the hydride is deﬁnitively bonded to the D-
glycerol carbon C3, and the proton H4 from His110 has been
completely transferred to D-glycerol oxygen O4. A strong
hydrogen bond involving H6 of Tyr48 persists, the O4···H6
distance being 1.72 Å.
We examined the possibility of an alternative mechanism
where the proton transfer (from H5(His110) to O4(GLD))
and the attack of the hydride on the C3 group occur in two
Figure 4. Reaction intermediates of the GLD reduction by AR with HIE110 as studied by the QM/MM model. (a) Enzyme−substrate complex, (b)
transition state 1, (c) enzyme−intermediate complex, (d) transition state 2, and (e) enzyme−product complex (distances shown in green, atom
numbers in brown, and residue names in red).
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separate steps. In spite of an extensive search, it was not
possible to locate any intermediate corresponding to the
alkoxide and thus the possibility of a two-step nonconcerted
mechanism was discounted. Finally, the mechanism with a
proton transfer from Tyr48 was also intensively investigated,
but no transition state that could lead to a proton transfer from
Tyr48 could be identiﬁed.
It is also informative to superpose the three stationary points
along the potential energy surface (PES; Figure 3d). The
aldehyde hydrogen of the reactant maintains its location in the
TS but is replaced by the NADPH hydride hydrogen at the
product stage. This suggests that the active site is set up to
stabilize a hydrogen at this point and is ideally arranged for this
transformation.
2.2. Mechanism with HIE110. For HIE, the mechanism is
constituted of two steps with an activation energy of 16.0 kcal/
mol (Scheme 2b and Figure 2). A schematic representation of
the starting enzyme−substrate complex (E−R), the two
transition states (E−TS1 and E−TS2), the intermediate (E−
I), and the ﬁnal enzyme−product complex (E−P), including
only the closest atoms around substrate, is given in Figure 4a−
e.
The same interactions that help to maintain atoms in the ES
complex of P−R can be found in E−R. These are hydrogen-
bonding interactions between both His110 and Tyr48 residues
and the carbonyl oxygen of GLD (H5(His110)···O4(GLD) =
1.86 Å and H6(Tyr48)···O4(GLD) = 1.89 Å) and the
interaction between the amide group of NADPH and the
middle hydroxyl group of GLD (O8(NADPH)···H9 = 1.72 Å)
(Figure 4a). A water molecule also stabilizes the 3-hydroxy of
GLD (O13(GLD)···H2O = 2.23 Å). Compared to P−R, E−R is
further stabilized by a supplementary interaction with Trp111
(H11(Trp111)···O10(GLD) = 2.06 Å) that is not always
present in the HIP simulation.
In the transition state, E−TS1 (characterized by an imaginary
frequency of −562 cm−1), the NADPH hydride transfer from
C1 to C3 is nearly completed, the C1···H2 and C3···H2
distances being 1.54 and 1.24 Å, respectively (Figure 4b).
Hydrogens from Tyr48 and His110 are both almost at the same
distance to the carboxyl oxygen of GLD O4 and closer
compared to E−Rthe H5(His110)···O4(GLD) distance was
1.86 Å in E−R but is 1.69 Å in E−TS1, and the H6(Tyr48)···
O4(GLD) distance was 1.89 Å in E−RE−R but is 1.66 Å in E−
TS1. The H11(Trp111) to O10(GLD) distance is nearly
unchanged from the E−R (2.06 Å) to E−TS1 (2.02 Å). The
interaction between the amide group of NADPH and the 2-
hydroxy of GLD (O8(NADPH)···H9(GLD) = 1.74 Å) is
relatively unchanged at E−TS1 compared to E−R, suggesting
that the function of this interaction is to maintain the position
of the substrate through a consistently strong stabilizing
interaction.
The transition from E−I to E−TS is almost barrier-less with
a diﬀerence of 0.4 kcal/mol. In the intermediate, E−I, the
NADPH hydride is now completely transferred from C1 to C3
Figure 5. (a) Comparison of NADPH position between HID (green) and HIE (orange) after a 1 ns molecular dynamics (MD) simulation. (b−d)
Reaction intermediates of the D-glyceraldehyde reduction by AR with HID110 as studied by the QM/MM model: (b) enzyme−substrate complex,
(c) transition state, (d) enzyme−product complex (distances shown in green, atom numbers in brown, and residue names in red).
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as C3···H2 is 1.13 Å, the distance of a C−H bond. The
diﬀerence between His110 and Tyr48 is clear in the
intermediate structure as Tyr48 H6 is closer to the GLD O4
(1.48 Å) than His110 H5 is to O4 (1.62 Å).
In the second transition state, E−TS2 (characterized by an
imaginary frequency of −305 cm−1), the hydrogen bonding
from Tyr48 and His110 to the GLD carbonyl oxygen O4 is
further diﬀerentiated. This proton is partially transferred from
Tyr48 (H6(Tyr48)···O4(GLD) =1.36 Å) compared to His110,
in which the hydrogen bonding remains consistent relative to
I−E (1.62 Å).
In the ﬁnal EP complex, E−P, the proton H6 from Tyr48 is
bonded to O4 from GLD. At this stage, a strong interaction is
formed between the formed Tyr48 phenolate and Lys77, going
from 1.86 Å in E−TS2 to 1.65 Å in E−P.
2.3. Mechanism with HID110. During the HID110 1 ns
MD simulation, a displacement of NADPH occurred (Figure
5a), giving an unproductive complex and perhaps suggesting
that this electronic state is quite unreactive. To address this
issue, the energy proﬁle for HID was determined with a new 1
ns MD but with restraints on the cofactor position.
For HID, the eventually identiﬁed mechanism is a concerted
one, using Tyr48 as proton donor with an activation energy of
26 kcal/mol (Scheme 2c and Figure 2). A schematic
representation of the starting enzyme−substrate complex
(D−R), the transition state (D−TS1), and the ﬁnal enzyme−
product complex (D−P), including only the closest atoms
around substrate, is given in Figure 5b−d.
In the case of HID, there are fewer interactions that help to
maintain atoms in the ES complex, D−R, in a suitable position
for reactions. As Nε of His110 is deprotonated, no stabilization
is possible. In contrast to the other simulations, no water was
observed interacting with the 3-hydroxy of GLD. As a
consequence, the interaction between the Tyr48 hydroxyl
group and O4 of GLD carbonyl group is strong (H6(Tyr48)···
O4(GLD) = 1.69 Å), whereas in P−R and E−R, the hydrogen
bond was longer, 2.02 and 1.89 Å, respectively (cf. Figure 5b,
3a, and 4a). The NADPH hydride is almost at the same
distance from the GLD carboxyl carbon (H2(NADPH)···
O4(GLD) = 2.28 Å) compared to E−R (2.25 Å) but slightly
further compared to P−R (2.00 Å). The hydrogen bond
between the GLD 2-hydroxy and Trp111 is fairly consistent
between both D−R (2.19 Å) and E−R (2.20 Å).
In the transition state, D−TS1 (characterized by an
imaginary frequency of −875 cm−1), the NADPH hydride is
moving from C1(NADPH) to C3(GLD). The hydride is very
close to completely transferred as the distance to C3 is only
1.20 Å. The proton from Tyr48 is approximately halfway
between O7(Tyr48) and O4(GLD) (H6···O7(Tyr48) distance
is 1.18 Å and H6(Tyr48)···O4(GLD) distance is 1.26 Å.) Thus,
the mechanism is concerted, indeed almost simultaneous,
between the hydride transfer and the proton transfer.
In the ﬁnal EP complex, D−P, the hydride is deﬁnitively
bonded to D-glycerol carbon C3, and the proton H6 from
Tyr48 has been completely transferred to GLD O4. At this
stage, a strong H-bonding interaction is formed between the
phenolate of Tyr48 and Lys77 (1.44 Å).
2.4. Comparison between the Three Reaction Models.
The calculated activation barriers for HIP and HIE are of 8.1
and 16.0 kcal/mol, respectively. Thus, from an energetic point
of view, both mechanisms are diﬀerent. This is all the more true
when we average the results obtained from QM/MM studies
on other frames (one additional for HIP and two for HIE) that
we also studied (details of the structures are provided in the
Supporting Information). These gave an average of 6.5 ± 2.2
kcal/mol for HIP and 16.7 ± 1.0 kcal/mol for HIE. Also, it
should be pointed out that we are comparing ΔE with ΔG;
nevertheless, in these types of reaction, the contribution from
thermal and entropic eﬀects is expected to be small.17 It could
be concluded from these results that the mechanism with the
lower activation energy is the more probable one. Nevertheless,
the experimental activation free energy calculated from kinetics
constants is 14.8 kcal/mol.14 Thus, although the activation
energy with the HIP model is lower, the results from the HIE
model are closer to the experimental value. Given the
signiﬁcant diﬀerence (∼10 kcal/mol) between the calculated
activation energies that arises from considering the protonation
state of the histidine, the clear agreement of the HIE model
with the experimental data indicates that the experimental
system involves an unprotonated histidine in the binding site
with Tyr48 acting as the proton donor. These conclusions
based on the diﬀerence in the calculated activation barriers are
in agreement with the calculation of the pKa of the residues,
which has been done by Vaŕnai and Warshel12 that yielded an
estimated pKa of 8.5 for Tyr48 and a remarkably low value of
0.9 for His110. The study of the HID model gave a much
higher energy barrier of 26.5 kcal/mol. The diﬀerence in the
results of HIE and HID models demonstrates that the presence
of a proton on Nε of His110 is required for the correct
positioning of GLD.
2.5. Eﬀect of Basis Set Size and QM Region Size. The
goal of this work was to obtain an updated QM/MM model for
the reduction of GLD by AR to determine both the mechanism
of reaction and the eﬀect that a diﬀerent QM/MM method-
ology can have on the outcome of results. To reach that goal,
we have used a more accurate QM treatment and a larger QM
zone. Thus, in the following, the current results are compared
to those from previous studies.
Our HIP model can be compared to the results obtained by
Lee and co-workers,13 and our HIE model, to the results
obtained by Vaŕnai and co-workers.11 To help the comparison,
energies from both studies and this work are summarized in
Table 2. The structural characteristics were very similar to
previous studies and are thus described in the Supporting
Information.
Table 2. Comparison of Previous QM/MM Results from Lee and Co-Workers’a Model (Lee) and Vaŕnai and Co-Workers’b
Model (Var.) to HIP and HIE Modelsc
TS1 ΔE I ΔE TS2 ΔE P ΔE
E−TS1 16.0 E−I 12.4 E−TS2 12.8 E−P 3.9
Var.-TS1 41.2 Var.-I 33.6 Var.-TS2 34.7 Var.-P 10.3
P−TS1 8.1 P−P −17.7
Lee-TS1 21.2 Lee-P −12.4
aRef 13. bRef 11. cElectronic energies (ΔE) in kcal/mol are given relative to the reactant state for each system studied.
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From an energetic point of view, the results diﬀer
signiﬁcantly. For the HIE model, there is notable diﬀerence
in the activation energy between the work of Vaŕnai and co-
workers11 (41.2 kcal/mol) and this work (16.0 kcal/mol), a
diﬀerence of 25.2 kcal/mol. From the experimental activation
free energy calculated from kinetics constants of 14.8 kcal/mol,
we know that our model is in better agreement.14
For the HIP model, the individual inﬂuence of the QM
treatment and the QM size is summarized in Table 3.
In the study by Lee and co-workers, the relative energy to the
reactant of the TS for the His110 proton donor model,
obtained using 4-31G, was 21.2 kcal/mol.13 From our results,
we can see that the use of the more accurate B3LYP/6-31G*
method has signiﬁcantly changed the calculated relative
energies as we obtained an activation energy of 7.5 kcal/mol,
13.7 kcal/mol smaller than that obtained by the HF/4-31G
method. The combination of B3LYP/6-31G* and a larger QM
region did not signiﬁcantly alter the activation energy (7.5 kcal/
mol for the smaller region and 8.1 kcal/mol for the larger
region). However, the eﬀect on the relative energy of the
product to the reactant (−6.0 kcal/mol for the smaller region
and −17.7 for the larger region) was more substantial. Overall,
the results show that a meaningful gain in accuracy for the
comparison of the two potential reaction mechanisms is due
mostly to the developments in accuracy and eﬃciency of QM
methods.
3. CONCLUSIONS
Since 1992 and the ﬁrst suggestion of His110 and Tyr48 as
potential proton donors, there has been a long history of debate
on the catalytic mechanism of AR.7,18 Nevertheless, the
common opinion seemed to favor the Tyr48 proton donor
mainly because of crystallographic and mutagenesis
data.10,19−22
Nevertheless, two previous QM/MM methodologies (using
CHARMM2223/HF 4-31G and CHARMM2223/AM124) have
failed to validate the Tyr48 hypothesis. Furthermore, they have
also given diﬀerent results between them for the proposed
mechanism: one predicted a concerted mechanism, whereas the
other predicted a stepwise mechanism. Using a diﬀerent force
ﬁeld and QM method (OPLS2005 and B3LYP25,26/6-31G*27)
and a bigger QM region, the mechanism was reevaluated. For
the ﬁrst time, a diﬀerent mechanism is suggested depending on
the protonation state of His110. With HIP as protonation state
for His110, the results show an average activation energy of 6.5
± 2.2 kcal/mol and evidence for a highly asynchronous
concerted mechanism with His110 as proton donor. With HIE,
the mechanism is diﬀerent, as results show an average activation
energy of 16.7 ± 1.0 kcal/mol and evidence for a stepwise
mechanism using Tyr48 as proton donor. Preliminary MD
simulation on HID indicates that this protonation state is
unreactive and shows the importance of a proton on Nε of
His110 for the reaction to occur as this residue is implicated in
the positioning of the substrate prior to the reaction. Our
results demonstrate that the HIP and HIE model mechanisms
are signiﬁcantly diﬀerent in energy and that only the HIE
model is in good agreement with experimental data
conﬁrming that Tyr48 is the most probable proton donor.
Finally, the eﬀect of using modern DFT methods for the QM/
MM calculation was evaluated by comparing our results to
those of previous studies. We found that the changes in
energetics can be substantially aﬀected by the choice of
methods and, importantly, the size of the QM site (particularly
for the relative energy of the reactants and products).
4. COMPUTATIONAL METHODS
4.1. Model Systems. Theoretical studies were performed
starting with an X-ray crystal structure (PDB ID: 1ADS) of the
aldose reductase enzyme that has a resolution of 1.65 Å.7
Although there are many other available crystal structures, this
provided a convenient point of reference, as the structure was
used in the previous QM/MM studies by Lee and co-workers.13
The structure includes the cofactor NADP, so this was
transformed into the reacting form NADPH. The “structure
preparation” module of molecular operating environment28 was
used to prepare the structure: missing hydrogens were added,
orientated, and the protonation states of residues were
optimized.
Particular attention was paid to His110 because, at
physiological pH, histidine can exhibit three diﬀerent
protonation states: HIP (protonated Nε and Nδ), HIE
(protonated Nε), and HID (protonated Nδ) (Scheme 3).29,30
Within a protein, standard pKa values of residues can be more
or less inﬂuenced by the environment and that makes the
prediction of the residues’ protonation state less straightfor-
ward. Diﬀerent methods exist to predict the pKa of residues, but
results from these prediction are not always reliable.31 In this
case, we have not attempted to do a QM/MM pKa prediction,
rather the initial calculation of the protonation states was
carried out with the empirical modeling program PROPKA.32
However, the calculated protonation states from this program
were found to be unreliable for the system under study. As
such, all possible protonation states for the histidine residue
involved in the mechanism were evaluated.
D-Glyceraldehyde (GLD) was chosen as the ligand, to be
consistent with the reference studies.11,13 The accuracy of the
MM force-ﬁeld parameters associated to GLD was tested by
performing various conformational searches and minimizations
with MacroModel.33 The consistency of the bonds and angles
of the resulting structures was checked using Mogul.34 As the
crystal structure did not contain any ligand, GLD was added
manually. To ensure that the re face of the carbonyl of GLD
would be able to receive the hydride from the NADPH, the
carbonyl oxygen of GLD was positioned within the range of
hydrogen-bonding interactions with the Nε hydrogen of
His110 and the hydroxyl of Tyr48. To get an adequate pose,
Table 3. Eﬀect of QM Treatment and QM Size on the
Activation Energy for the HIP Modelc
QM treatment HF/4-31G B3LYP/6-31G* B3LYP/6-31G*
QM/MM partitioninga 1 1 2
Ea 21.2
b 7.5 8.1
ΔE −12.4b −6.0 −17.7
aAs deﬁned in Figure 2. bRef 13. cElectronic activation energies (Ea)
and reaction energies (ΔE) in kcal/mol are given relative to the
reactant state for each system studied.
Scheme 3. Diﬀerent Protonation States of Histidine
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an optimization with constraints on the distances of these
hydrogens bonds was run to reproduce the distances from the
Michaelis complex (MC) described by Lee and co-workers.13
After having deleted all crystal waters, the system was solvated
in a 10 Å orthorhombic box of water using the system builder
panel of Desmond.35,36 TIP4P37 was chosen as the model for
the waters. Finally, to neutralize the system, three sodium
atoms were added randomly for the HIP model and four for
both HIE and HID models.
The three model systems were gradually relaxed using a
standard protocol implemented in Desmond.35,36 This protocol
comprises a series of minimizations and molecular dynamics,
starting from a system where only hydrogens and the solvent
are free to move as the system is gradually relaxed. A molecular
dynamics (MD) simulation was performed for 1 ns using
Desmond35,36 to relax further the system and to obtain a variety
of snapshots for the QM/MM calculations. The NPT ensemble
was used for the simulation with the Martyna, Tuckerman, and
Klein method.38 The temperature was kept ﬁxed at 300 K. The
cutoﬀ radius for the nonbonded interactions (Coulombic and
van der Waals) was ﬁxed at 9.0 Å without any special treatment
of interactions at the cutoﬀ. The long-range Coulombic
interactions in the simulation were treated by a smooth particle
mesh Ewald method with a tolerance value of 1 nm.39 At the
end of the MD simulation, the average value, the standard
deviation, and the slope of diﬀerent properties (potential
energy, pressure, temperature, and volume) were calculated and
analyzed to conﬁrm that the MD simulation was at equilibrium.
To obtain an averaged energy barrier, a minimum of two
snapshots per model, with suitable hydrogen bonding between
GLD and both His110 and Tyr48, were extracted from the MD
output and prepared for QM/MM calculations. The selected
snapshots were then MM minimized to return the system to 0
K using the truncated Newton method40 implemented in
Impact.41 A second MM minimization using the Polak−Ribiere
conjugate gradient42 method implemented in MacroModel33
was used to reproduce the distances from the Michaelis
complex described by Lee and co-workers.13 All of the
minimizations were done with waters’ oxygen atoms kept
constrained. These postequilibration minimized structures,
which represent the enzyme−substrate (ES) complex, were
used as starting structures for the QM/MM calculations.
4.2. QM/MM Methodology. In previous QM/MM studies
by Lee and co-workers13 and Vaŕnai and co-workers,11 the
choice of the QM region for both studies includes all
hypothetical reacting species (D-glyceraldehyde, NADPH,
His110, and Tyr48) and inﬂuential residues (Asp43 and
Lys77).18 An increase in accuracy can be expected if the size of
the QM region is extended;43,44 currently, QM/MM
calculations can readily account for up to 100 atoms in the
QM region,45 so performing calculations on the upper side of
this range could thus be considered. The QM treatment was
done at an ab initio level (HF/4-31G) by Lee and co-workers13
and at a semiempirical level (AM1)24 by Vaŕnai and co-
workers.11 Although issues such as boundary eﬀects, the
classical potential, and optimization strategies may all aﬀect
calculated results, in this comparison, the diﬀerence between
the QM treatment of the system could be the main reason for
lack of accuracy in the previous results. As such, this hypothesis
will be tested in the current work. Ideally, one would perform
all QM calculations with the most accurate ab initio method,
together with the largest available basis set.46 The most
generally reliable and routinely used QM treatment in current
QM/MM studies is DFT, particularly with the B3LYP
functional.25,45
To study the reaction, a hybrid QM/MM Hamiltonian was
employed using QSite.47−49 For the classical region (MM), the
OPLS_200550 force ﬁeld was used to describe the protein. The
QM region was modeled at the B325LYP26,51/6-31G*27 level of
theory. The eﬀect of the size of the QM region was examined
using two diﬀerent QM regions on the HIP model. The ﬁrst
QM region was deﬁned as in the study by Lee and co-
workers.13 This QM region with a total of 54 atoms is
represented in Figure 6a. A larger QM/MM partitioning, as
deﬁned in Figure 6b, was also used in the three models (HIP,
HIE, and HID). In this second partitioning, the same residues
are included, but the QM/MM frontier is positioned diﬀerently.
First, the entire side chains of residues were included by cutting
between Cα and Cβ. Second, the frontier within NADPH was
extended by adding the ribose part of NADPH, allowing a cut
between two carbons rather than between a carbon and a
nitrogen atom, consistent with the best practice for the
positioning of link atoms.52 The QM/MM partitioning 2 thus
Figure 6. QM/MM partitioning (a) 1 and (b) 2. The QM region is shown in green, and the yellow dots represent link atom positions.
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had a total of 90 atoms included for the HIP model and 89
atoms for both HIE and HID models.
To be consistent with the reference study, the link atom
approach was used to saturate the valence of the QM/MM
frontiers.13,53 To avoid overpolarization of QM atoms by MM
atoms to the boundary, Gaussian charge distributions were used
to represent the potential of the atoms within two covalent
bonds of the QM/MM cut-site using the Gaussian grid method
for hydrogen cap electrostatics in QSite.54 MM point charges
were employed for the rest of the MM region.
All atoms beyond 10 Å from the reactant were consistently
kept constrained during the QM/MM simulations to speed up
the calculations. The equilibrated ES complex was optimized
with QM/MM calculations. The potential energy surface (PES)
for the reaction was explored starting from this optimized
structure of the reactant. Transition states (TS) were identiﬁed
by means of a micro/macroiteration scheme, with all pure MM
atoms being adiabatically minimized at each TS search step.55
This TS search calculation was done in QSite47,48 using the
standard method. This takes an initial guess of the TS as input
and tries to ﬁnd the closest saddle point to it. The initial guess
was built by small modiﬁcations of the optimized structure of
the reactant, the goal being to make it resemble as much as
possible the believed transition state. To do so, the reacting
bond C1−H2 (the carbon−hydride bond of the NADPH) was
elongated manually to position the hydride halfway between
the C1 carbon, where the hydride is initially attached, and the
GLD carbonyl carbon C3. The carboxyl double bond of the
GLD was also elongated to mimic the transition from a
carbonyl double bond to an alcohol single bond. Also, to help
the TS search process, QSite allows one to indicate as an input
what bonds are supposed to be made or broken. This was done
by adding a connect section to the input ﬁle, where C1−H2
hydride bond was deﬁned as the reaction coordinate. To ﬁnd
the reactant and product associated with this saddle point, the
TS was minimized at the same level of theory. The nature of
the structures was conﬁrmed from the analysis of the Hessian.
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Math. Anal. Numeŕ. 1969, 3, 35−43.
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